home / stock / nktr / nktr quote
Last: | $1.29 |
---|---|
Change Percent: | -0.77% |
Open: | $1.31 |
Close: | $1.29 |
High: | $1.335 |
Low: | $1.18 |
Volume: | 2,299,917 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.29 | $1.31 | $1.29 | $1.335 | $1.18 | 2,299,917 | 07-05-2024 |
$1.3 | $1.17 | $1.3 | $1.33 | $1.17 | 1,445,714 | 07-04-2024 |
$1.3 | $1.17 | $1.3 | $1.33 | $1.17 | 1,445,714 | 07-03-2024 |
$1.17 | $1.2 | $1.17 | $1.25 | $1.1 | 1,432,921 | 07-02-2024 |
$1.22 | $1.25 | $1.22 | $1.31 | $1.13 | 2,353,532 | 07-01-2024 |
$1.24 | $1.16 | $1.24 | $1.3 | $1.1203 | 25,169,074 | 06-28-2024 |
$1.14 | $1.09 | $1.14 | $1.19 | $1.07 | 2,123,996 | 06-27-2024 |
$1.085 | $1.05 | $1.085 | $1.12 | $1.01 | 1,708,109 | 06-26-2024 |
$1.07 | $1.16 | $1.07 | $1.16 | $1.06 | 1,781,490 | 06-25-2024 |
$1.17 | $1.12 | $1.17 | $1.24 | $1.09 | 2,201,087 | 06-24-2024 |
$1.16 | $1.08 | $1.16 | $1.17 | $1.04 | 2,580,941 | 06-21-2024 |
$1.09 | $1.14 | $1.09 | $1.19 | $1.06 | 1,274,440 | 06-20-2024 |
$1.14 | $1.16 | $1.14 | $1.16 | $1.11 | 824,440 | 06-19-2024 |
$1.14 | $1.16 | $1.14 | $1.16 | $1.11 | 824,440 | 06-18-2024 |
$1.17 | $1.18 | $1.17 | $1.19 | $1.13 | 1,392,690 | 06-17-2024 |
$1.17 | $1.22 | $1.17 | $1.235 | $1.17 | 952,107 | 06-14-2024 |
$1.25 | $1.32 | $1.25 | $1.32 | $1.22 | 1,119,028 | 06-13-2024 |
$1.29 | $1.26 | $1.29 | $1.385 | $1.26 | 1,292,210 | 06-12-2024 |
$1.26 | $1.23 | $1.26 | $1.27 | $1.17 | 932,488 | 06-11-2024 |
$1.205 | $1.26 | $1.205 | $1.3 | $1.19 | 2,532,628 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024 PR Newswire – NKTR-0165 Demonstrates Selective Enhancement of Treg Cell Function Through Novel Agonistic ...
Nektar Management to Present at Upcoming Investor Conferences PR Newswire SAN FRANCISCO , May 30, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: Jefferies Healthcare C...
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...